Table 2

Risk of high-grade dysplasia or malignancy according to dilatation of the main pancreatic duct in IPMN

ReferenceStudy designNumber of patientsMPD dilatationPatients with either high-grade dysplasia or malignancy (%)
Ogawa et al 127 2008Retrospective61≥6 mm91
Shin et al 128 2010Retrospective204≥6 mm30
Abdeljawad et al 95 2014Retrospective52≥8 mm56
Hackert et al 94 2015Retrospective320≥5 mm59
Seo et al 93 2016Retrospective158≥5 mm49
  • MPD, main pancreatic duct.